Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,728 public trials 404 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Active, Not Recruiting

DreaMS - Validation Study 1

NCT05009160

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Neurozentrum, Kantonsspital Aarau Aarau, Switzerland
  • Department of Neurology, CHUV Lausanne Lausanne, Switzerland
  • Centro Sclerosi Multipla, Ospedale Regionale di Lugano Lugano, Switzerland
  • Klinik für Neurologie, Kantonsspital St. Gallen Sankt Gallen, Switzerland
View Trial Details
Active, Not Recruiting

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

NCT00716066

Conditions
Autoimmune Disease, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +59 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Swedish Medical Center-First Hill Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

NCT05134441

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Xenoscience, Inc., 21st Century Neurology Phoenix, Arizona, United States
  • Regina Berkovich MD, PhD Inc. MS Neurology West Hollywood, California, United States
  • Bradenton Research Center Bradenton, Florida, United States
  • Collier Neurologic Specialists Naples, Florida, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

NCT05201638

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neuro of Central Florida Altamonte Springs, Florida, United States
  • Healthcare Innovations Coral Springs, Florida, United States
  • Heratsi Hospital Complex 1 Yerevan, Armenia
  • Saint Gregory the Illuminator Medical Center Yerevan, Armenia
View all 76 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

NCT04035005

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MS and Neuromuscular Center of Excellence Clearwater, Florida, United States
  • Neurological Services of Orlando Orlando, Florida, United States
  • Vero Neurology Vero Beach, Florida, United States
View all 155 locations
View Trial Details
Active, Not Recruiting

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

NCT04530318

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Hospital Moisés Broggi L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
  • Hospital de Sant Pau Barcelona, Spain
View Trial Details
Active, Not Recruiting

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT06372145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • The University of Alabama at Birmingham- Site Number : 8400013 Birmingham, Alabama, United States
  • ~North Central Neurology Associates, PC- Site Number : 8400009 Cullman, Alabama, United States
  • Center for Neurology and Spine- Site Number : 8400089 Phoenix, Arizona, United States
  • Collaborative Neuroscience Research- Site Number : 8400045 Los Alamitos, California, United States
View all 352 locations
View Trial Details

Related conditions